ARCHIVES

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Kristian Storm Names Chief Of Surgical Oncology At Univ. Of Wisconsin; Skibba To Join CTEP

November 13, 1987

In Congress: Mack Urges Stevens To Add $2 Billion To NIH Appropriations

June 13, 1997

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

Funding opportunities listed.

February 20, 2004

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000